• Users Online: 309
  • Print this page
  • Email this page
INVITED REVIEW ARTICLE
Year : 2019  |  Volume : 21  |  Issue : 1  |  Page : 1-8

How to optimize aerosol drug delivery during noninvasive ventilation: What to use, how to use it, and why?


Department of Respiratory Care, Texas State University, Texas, USA

Correspondence Address:
Dr. Arzu Ari
Department of Respiratory Care, College of Health Professions, Texas State University, 200 Bobcat Way, Room 214, Round Rock, Texas
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ejop.ejop_10_19

Rights and Permissions

Much evidence supports the use of non-invasive ventilation (NIV) in patients who have acute and chronic respiratory failure and aerosolized medications are increasingly used in this patient population. Successful application of aerosol therapy during NIV depends on the effectiveness of the drug deposition in the lungs. Previous evidence showed that many factors impact aerosol delivery to patients receiving NIV. Those factors include mode of ventilation, ventilator parameters, type of ventilator circuit, the position of the aerosol device, the location of leak port, type of exhalation valve, humidity, enhanced condensational growth, type of aerosol device, and interface as well as delivery technique. The purpose of this paper is to review the available evidence related to aerosol therapy during NIV and provide recommendations to optimize aerosol drug delivery to patients receiving NIV.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed588    
    Printed38    
    Emailed0    
    PDF Downloaded148    
    Comments [Add]    

Recommend this journal